COMPARE · Data as of August 28, 2026

OHI vs SBRA

Verdict: Side-by-side breakdown using the Bull Rankings model. OHI scored 72.0, SBRA scored 71.0 — OHI leads.
Compare another set
OHI
Omega Healthcare Investors, Inc.
REIT - Healthcare Facilities · Financial strength
74.6Fin
$46.03 · $14.7B
fundamentals as of
Strength gap
9.5
OHI leads
SBRA
Sabra Health Care REIT, Inc.
REIT - Healthcare Facilities · Financial strength
65.1Fin
$20.70 · $5.3B
fundamentals as of
  • Fastest growthOHI+13.2%
  • Strongest balance sheetOHI0.71
THE BULL RANKINGS SCORECARD74.6/ 100 · FIN STRENGTHPEER MEDIANREIT74.6
THE BULL RANKINGS SCORECARD65.1/ 100 · FIN STRENGTHPEER MEDIANREIT65.1
YieldOHI5.8%SBRA5.8%
RevOHI+13.2%SBRA+10.2%
D/EOHI0.71SBRA0.96
OHI
SBRA
5.8%A-
Yield
5.8%A-
+13.2%B+
Rev
+10.2%B
0.71B+
D/E
0.96B
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
OHIOmega Healthcare Investors, Inc.
REIT - Healthcare Facilities · $46.03 · beta 0.58
Why now
REIT - Healthcare Facilities · market cap $14.7b. 12% off the 52-week high of $52.39. Revenue growing +13%, comfortably above the S&P median. 18 sell-side analysts rate this a Buy with a mean 1-yr target of $51.94 (implying +13% upside).
Moat
Net margin 68% is exceptional — pricing-power territory rare outside premium software, branded staples, and specialty pharma. ROE 17% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately.
Risk
Dividend payout 95% of earnings on a 5.8% yield — distribution coverage is thin; one earnings stumble could force a dividend cut. P/S 11.7x embeds aggressive forward growth — disappointing top-line guidance would compress the multiple hard.
SBRASabra Health Care REIT, Inc.
REIT - Healthcare Facilities · $20.70 · beta 0.64
Why now
REIT - Healthcare Facilities · market cap $5.3b. 9% off the 52-week high of $22.77. Revenue growing +10%, comfortably above the S&P median. 14 sell-side analysts rate this a Buy with a mean 1-yr target of $22.57 (implying +9% upside).
Moat
Moat signals from the quantitative card are modest — profitability and capital efficiency are middle-of-pack. The thesis here depends on softer factors (switching costs, brand, distribution, regulatory protection) not captured by the quality-growth screen.
Risk
Dividend payout 462% of earnings on a 5.8% yield — distribution coverage is thin; one earnings stumble could force a dividend cut. ROE 2% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.